Key result
E-cigarette cooling agents WS-3 and WS-23 dose-dependently increase autonomic imbalance and ventricular arrhythmias in mice.
Why the study?
Cooling agents such as menthol, WS-3, and WS-23 enhance electronic cigarette appeal, but their risks regarding autonomic imbalance and cardiac arrhythmia when inhaled remain unknown.
Cooling agents in electronic cigarettes, particularly synthetic coolants WS-3 and WS-23, enhance arrhythmogenicity and autonomic imbalance in preclinical models.
WS-23 and similar coolants may heighten e-cig arrhythmia risk in users; leaves open human translation and regulatory action.
BACKGROUND: Despite the growing popularity of electronic cigarettes, evidence is mounting that vaping induces autonomic nervous system imbalance, cardiac arrhythmia, and potentially even cardiac arrest. The ingredients menthol, Wilkinson Sword (WS)-3, and WS-23 are cooling agents that enhance the appeal of electronic cigarettes (e-cigs) but bear unknown risks when inhaled. METHODS: We systematically evaluated how these coolants influence the impacts of e-cigs on cardiac and cellular electrophysiology in mice and human induced pluripotent stem cell-derived cardiomyocytes, respectively. Mice were exposed by inhalation to e-cig aerosols generated from standard e-liquid solvents and 2.5% nicotine benzoate (vehicle), or from vehicle plus menthol, WS-3, or WS-23, at increasing concentrations throughout exposure. Telemetry-derived electrocardiograms were analyzed for changes in heart rate, heart rate variability, morphology, and ventricular premature beat arrhythmias. Human induced pluripotent stem cell-derived cardiomyocytes were evaluated for the effects of serially increasing coolant concentrations on beat rate, electric field potential duration, and rate-corrected field potential duration from a newly validated formula, in the absence and presence of norepinephrine to simulate basal physiology and nicotine-evoked sympathoexcitation. RESULTS: Upon e-cig aerosol inhalation, all coolants acutely enhanced vehicle-induced autonomic imbalance, but only the synthetic coolants, WS-3 and WS-23, potentiated ventricular arrhythmogenesis. Ventricular premature beats during e-cig exposures correlated with sympathetic dominance and transient delays in ventricular repolarization measured by heart rate variability and QT interval corrected by RR interval, respectively; however, correlations were strongest for WS-23 despite no significant impact of coolants on nicotine intake. Conversely, in human induced pluripotent stem cell-derived cardiomyocytes, coolants did not affect basal physiology but slowed beat rate and shortened rate-corrected field potential duration during norepinephrine stimulation. CONCLUSIONS: Together, these data indicate that coolants dose-dependently enhance the arrhythmogenicity of e-cigs, likely through acute alterations in autonomic modulation and repolarization. Pending confirmation by human studies, these common nonnicotine additives may exacerbate e-cig cardiotoxicity and pose unique cardiovascular risks, particularly in those with arrhythmogenic susceptibility to sympathetic stimulation or slowed ventricular repolarization.
No takes yet. Share an insight, caveat, or question.
Kucera et al. (2026) studied E-cigarette cardiotoxicity and arrhythmogenesis. E-cigarette aerosols with cooling agents (menthol, WS-3, WS-23) vs. vehicle (standard e-liquid solvents and 2.5% nicotine benzoate) was evaluated on cardiac and cellular electrophysiology (heart rate, heart rate variability, morphology, ventricular premature beat arrhythmias). E-cigarette cooling agents WS-3 and WS-23 dose-dependently enhanced autonomic imbalance and potentiated ventricular arrhythmogenesis in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: